Acurx Pharmaceuticals (ACXP) Enterprise Value (2021 - 2026)
Acurx Pharmaceuticals' Enterprise Value was -$3.44 million in Q2 2026, compared with $6.1 million a year earlier.
Powered by 
Analysis
Acurx Pharmaceuticals (ACXP) Enterprise Value (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, Acurx Pharmaceuticals' Enterprise Value was -$26.2 million through Jun 30, 2026; for FY2025, it was -$3.82 million.
- In earlier years, Enterprise Value was $10.16 million in FY2024 (-78.8%), $47.94 million in FY2023 (+29.0%), $37.17 million in FY2022 (+19.2%) and $31.18 million in FY2021.
- Quarterly Enterprise Value has moved between -$3.82 million (Q4 2025) and $47.94 million (Q4 2023) over five years.
- Compared with a year earlier, Enterprise Value was higher in 1 of the last six quarters, with an average decline of 51.5%.
- The best year-over-year quarter for Enterprise Value over five years was Q3 2024 (growth of 109.6%); the worst was Q3 2025 (a decline of 93.0%).
- Per Business Quant data, ACXP's Enterprise Value in the three quarters before Q2 2026 was $785,387 (Q1 2026), -$3.82 million (Q4 2025) and $1.82 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn |
| 10 | Acurx Pharmaceuticals | 4.92 Mn | -28.54 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.44 Mn |
| Mar 31, 2026 | 785,386.53 |
| Dec 31, 2025 | -3.82 Mn |
| Sep 30, 2025 | 1.82 Mn |
| Jun 30, 2025 | 6.10 Mn |
| Mar 31, 2025 | 4.09 Mn |
| Dec 31, 2024 | 10.16 Mn |
| Sep 30, 2024 | 26.10 Mn |
| Jun 30, 2024 | 29.63 Mn |
| Mar 31, 2024 | 29.68 Mn |
| Dec 31, 2023 | 47.94 Mn |
| Sep 30, 2023 | 12.46 Mn |
| Jun 30, 2023 | 25.32 Mn |
| Mar 31, 2023 | 33.21 Mn |
| Dec 31, 2022 | 37.17 Mn |
| Sep 30, 2022 | 24.17 Mn |
| Jun 30, 2022 | 29.81 Mn |
| Mar 31, 2022 | 22.58 Mn |
| Dec 31, 2021 | 31.18 Mn |
| Sep 30, 2021 | 37.59 Mn |
API Access
Acurx Pharmaceuticals Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=ACXP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "ACXP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=ACXP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();